Radiation Safety After Lu-177 PSMA Therapy: Your Complete Guide to Precautions, Contamination Risks, and Safe Return to Daily Life

This article is for men with metastatic castration-resistant prostate cancer (mCRPC) who have received - or are preparing for - lutetium Lu-177 vipivotide tetraxetan, the radioligand therapy known by the brand name Pluvicto. After each infusion, your body carries low-level radiation for a short period. Understanding the precautions - and why they exist - helps you protect the people you live with while you recover. Most measures last just a few days, and you are not in danger.

If you are still deciding whether this treatment is right for you, the guide to how Lu-177 PSMA works covers the science before you get to the safety steps here.

What Are the Main Radiation Safety Precautions After Lu-177 PSMA Therapy?

Here is a short checklist you can share with your family or caregiver before you come home from your infusion:

1. Drink plenty of fluids and urinate often during the first 24 hours.
2. Flush the toilet two or three times after each use for the first three days.
3. Sleep in a separate bedroom from household members for at least three days.
4. Keep at least one metre (about three feet) of distance from others during close contact for the first two days.
5. Avoid prolonged close contact with children and pregnant women for at least seven days.
6. Wear disposable gloves when handling soiled clothing, bedding, or any bodily fluids.
7. Wash any soiled laundry separately, once, on a standard machine cycle.

Each of these points is explained in more detail below.

Why Does Your Body Carry Radiation After Treatment?

Lutetium-177 is a radioactive element attached to a targeting molecule. Together, they seek out PSMA - a protein found on prostate cancer cells. When the molecule binds to a cancer cell, the lutetium-177 releases energy that damages the cell's DNA from inside. This is what makes the therapy effective.

But not all of the drug binds to tumor cells. A portion travels through the bloodstream, and your kidneys filter it out. It then leaves your body mainly through urine. As it decays and clears, it also releases a small amount of gamma radiation - a type that can travel outside your body and reach people nearby. The precautions you follow help keep the radiation dose your family receives within safe limits set by nuclear medicine regulators. They are precautionary and temporary, not a sign that you are dangerous.

How Quickly Does the Radiation Leave Your Body?

Faster than most patients expect.

Clinical best-practice guidance on radiation safety during lutetium-177 therapy shows that about 50% of the administered dose is excreted in urine within the first four hours after infusion. This is why your care team asks you to urinate before you leave the treatment center and again as soon as you get home.

The physical half-life of lutetium-177 is approximately 6.7 days. This means the radiation level in your body naturally halves every six to seven days through radioactive decay. Your kidneys clear the drug at the same time. Together, these two processes clear more than 99% of the radiation from your body by day 14, as stated in the FDA prescribing information for Pluvicto. After that point, no special precautions are needed.

Radiation Safety at Home: Time, Distance, and Hygiene

Nuclear medicine teams manage radiation exposure at home using three basic principles: time, distance, and hygiene.

Time means keeping close interactions brief. The shorter the time you spend near others, the lower the dose they receive. Over the days after treatment, as radiation clears from your body, this concern fades quickly.

Distance means staying further apart when possible. Radiation intensity drops off rapidly with distance. Doubling the gap between you and another person reduces their exposure by roughly four times. Even one or two metres of separation helps in the first few days.

Hygiene means handling bodily fluids - especially urine - with care. Urine is how most of the lutetium-177 leaves your body, and it poses the main contamination risk in your home during the first three days after each infusion.

Bathroom and Toilet Precautions: What Matters Most

Most contamination happens in the bathroom because urine carries much of the drug out of your body in the hours after infusion.

Follow these steps for the first three days after each cycle:

• Sit down when urinating. This reduces splashing and limits contamination of the toilet seat and surrounding floor.
• Flush two or three times after every use.
• Use your own bathroom if your home has more than one. If you must share, clean all surfaces with regular household disinfectant after every use during the first three days.
• Wash your hands with soap and water after using the toilet.
• Clean the bathroom thoroughly at the end of the three-day period - toilet bowl and seat, sink, taps, floor, and any surfaces you regularly touch.

Some patients worry about the water supply. The small amounts of radioactivity in your urine pass through household sewage systems safely. You do not need special waste containers or a radiation disposal service.

How Close Can You Be to Family and Friends?

The guidance below reflects the Joint EANM/SNMMI procedure guideline for Lu-177 PSMA radioligand therapy and standard patient-release protocols used at major treatment centers. Your own team may adjust these based on the specific dose you received.

• General household members (adults): Limit time spent within one metre of others for approximately two days. Brief interactions - a conversation across the room, a meal at a table, passing in a hallway - are generally fine. What to avoid is prolonged close contact over many hours, such as sitting side by side on a sofa all evening or sharing a car for a long drive.
• Children under 18: Avoid prolonged close contact for seven days. Do not hold babies or young children on your lap during this period.
• Pregnant women: A developing baby is more sensitive to radiation than an adult. Avoid prolonged close contact with any pregnant person for seven days. Sleep in a separate room from a pregnant partner for up to 15 days.
• Sexual intimacy: Physical intimacy that involves close bodily contact should generally be avoided for at least one week after each infusion. Ask your nuclear medicine team for written instructions specific to your situation before you leave the treatment center.

Brief contact - a hug, a handshake, sitting together - is not a concern the way prolonged closeness is. The risk comes from time spent near others over the course of a day or night.

Sleeping Arrangements for the First Two Weeks

Sleep in a separate bedroom from household members for at least three days after each infusion. If you share a bed with a partner who is not pregnant, your team usually recommends sleeping apart for seven nights. If your partner is pregnant, sleep in a separate room for 15 days.

These times match how fast lutetium-177 leaves your body. They are not permanent changes to your life. Most couples return to normal sleep within two weeks, with no lasting disruption.

Handling Bodily Fluids and Household Items Safely

Urine is the main concern. Sweat, saliva, vomit, and stools carry much smaller amounts of radioactive material. Still, these basic steps help during the first three days:

• Wear disposable gloves if you need to clean up any bodily fluid - yours or anyone else's in your household.
• Laundry: Wash any clothing, bedding, or towels that may have come into contact with bodily fluids separately, once, on a standard machine cycle. Do not mix these items with the rest of the household laundry until the three-day period has passed.
• Personal items: Wipe down things you touch regularly - mobile phone, remote controls, door handles - with a damp cloth or household disinfectant wipe at the end of each day during the first three days.

After three days, a one-time clean of bathroom and kitchen surfaces with regular household products is all you need. Your home is clean - no special attention needed after this point.

Returning to Work, Public Spaces, and Air Travel

In most cases, you will be discharged from the treatment center on the same day as your infusion, after a short observation period of approximately four to five hours. Your care team will confirm you meet the release criteria before you leave.

For returning to work, the timing depends on your role and how you feel. If you work from home or in a private office, you may be able to return from day two or three. If your job involves prolonged close contact with others - especially children, nursing staff, or pregnant colleagues - discuss specific timing with your nuclear medicine team before your first cycle. For a detailed look at energy levels and what patients typically experience at work, the article on working during Lu-177 PSMA therapy covers this in full.

For air travel, you may set off radiation monitors at airports for several weeks after treatment. Airport security systems may detect the radiation. Always ask your treatment center for a wallet card or letter before you travel. This document explains to border and security personnel that you have received radiopharmaceutical therapy. Most major international airports are familiar with these letters.

How You May Feel in the First Few Days at Home

Many men feel tired in the two to five days after each Lu-177 PSMA infusion. Some notice mild nausea or a temporary drop in energy. These come from the treatment, not from the safety measures, and are separate from any contamination concern.

Plan for quiet days at home - lighter obligations, gentle activity, good hydration - to help with recovery. For a full picture of what to expect with post-infusion fatigue, the article on managing fatigue during and after Lu-177 PSMA therapy covers the causes and practical strategies in detail. Some patients also explore over-the-counter immune support options during recovery, like those offered by Ayurnomics's Immunity and Wellness range.

Once the safety period has passed and your care team has reviewed your response to the current cycle, you will begin thinking about what comes next. The guide on monitoring and follow-up care after your Lu-177 PSMA cycles explains which blood tests and scans your team will order and how to decide about continuing treatment.

Planning Your Home Before You Travel for Treatment

If you are traveling from outside the country for your Lu-177 PSMA infusion - for example, from the Gulf region, East Africa, or South Asia to a center in India - it helps to think through your home arrangements before you leave. Consider the following before your first cycle:

• Is there a separate bedroom you can use for the first week after returning from each cycle?
• Is there a bathroom you can use exclusively for the first three days?
• Do you have disposable gloves and basic cleaning supplies ready at home?
• Have your household members been told about the temporary precautions - especially any children or a pregnant family member?
• Does your workplace need a brief medical letter if you need a few extra days before returning?

If you are unsure whether you should stay near the treatment center between cycles or fly home, you can arrange a teleconsultation with the Art of Healing Cancer team before your first trip. They can help you plan the logistics of traveling home after each dose, advise on the timing between cycles, and clarify what precautions apply during travel so you know what to expect at the airport.

When to Talk to Your Doctor

Call your care team if you develop a fever above 38 degrees Celsius, unusual bruising, significant swelling, or signs of a urinary tract infection - such as burning, pain, or cloudy urine - after any cycle. These symptoms come from the treatment and need medical attention.

Also speak to your team if your household circumstances make the standard precautions difficult to follow - for example, if you live in a single room with a pregnant family member or a newborn. Your nuclear medicine team can offer guidance tailored to your situation. If you are still deciding whether Lu-177 PSMA therapy is the right next step, you can send your PSMA-PET results to the Lutetium Therapy team for an eligibility review. If Lu-177 turns out not to be the right fit for your case, the team can also discuss other treatment options with your oncologist.

This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.